Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetic Modulators as Potential Multi-targeted Drugs Against Hedgehog Pathway for Treatment of Cancer
Anshika Singh, Neeti Sharma
The Protein Journal (2019) Vol. 38, Iss. 5, pp. 537-550
Closed Access | Times Cited: 13

Showing 13 citing articles:

Nitrile-containing pharmaceuticals: target, mechanism of action, and their SAR studies
Xi Wang, Yuanxun Wang, Xuemin Li, et al.
RSC Medicinal Chemistry (2021) Vol. 12, Iss. 10, pp. 1650-1671
Open Access | Times Cited: 104
Targeting cancer stem cells in drug discovery: Current state and future perspectives
Fangyu Du, Qifan Zhou, Wenjiao Sun, et al.
World Journal of Stem Cells (2019) Vol. 11, Iss. 7, pp. 398-420
Open Access | Times Cited: 90
An up-to-date overview of computational polypharmacology in modern drug discovery
Rajan Chaudhari, Lon Wolf R. Fong, Zhi Tan, et al.
Expert Opinion on Drug Discovery (2020) Vol. 15, Iss. 9, pp. 1025-1044
Open Access | Times Cited: 66
Improved methods for targeting epigenetic reader domains of acetylated and methylated lysine
Isabelle A. Engelberg, Caroline A. Foley, Lindsey I. James, et al.
Current Opinion in Chemical Biology (2021) Vol. 63, pp. 132-144
Open Access | Times Cited: 17
ErbB2 Targeted Epigenetic Modulation: Anti-tumor Efficacy of the ADC Trastuzumab-HDACi ST8176AA1
Ferdinando Maria Milazzo, Loredana Vesci, Anna Maria Anastasi, et al.
Frontiers in Oncology (2020) Vol. 9
Open Access | Times Cited: 15
Molecular Structure, Binding Affinity, and Biological Activity in the Epigenome
Balázs Zoltán Zsidó, Csaba Hetényi
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 4134-4134
Open Access | Times Cited: 13
Epigenetically Mediated Ciliogenesis and Cell Cycle Regulation, and Their Translational Potential
Xiaoyan Li, Xiaogang Li
Cells (2021) Vol. 10, Iss. 7, pp. 1662-1662
Open Access | Times Cited: 10
Inhibition of EZH2 by chidamide exerts antileukemia activity and increases chemosensitivity through Smo/Gli-1 pathway in acute myeloid leukemia
Xuejie Jiang, Ling Jiang, Jiaying Cheng, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 9
Shen-Shuai-Ling Formulation Attenuates Renal Interstitial Fibrosis in Chronic Kidney Disease by Regulating SHH-Gli1 Signaling Pathway
Ying Li, Haitao Tu, Yan Luo, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 3
Computational investigation of naturally occurring anticancer agents in regulating Hedgehog pathway proteins
Renu Pai, Divijendranatha Reddy Sirigiri, Rajyalakshmi Malempati, et al.
PLoS ONE (2024) Vol. 19, Iss. 12, pp. e0311307-e0311307
Open Access
Basics of Polypharmacology
Zhiguo Wang, Baofeng Yang
Springer eBooks (2022), pp. 1-41
Closed Access | Times Cited: 1
The multitarget approach as a green tool in medicinal chemistry
Rita Bernadett Vlocskó, Sinem Apaydın, Béla Török, et al.
Elsevier eBooks (2022), pp. 457-492
Closed Access | Times Cited: 1
Inhibition of EZH2 by chidamide exerts antileukemia activity and increases chemosensitivity through Smo/Gli-1 pathway in acute myeloid leukemia
Xuejie Jiang, Ling Jiang, Jiaying Cheng, et al.
Research Square (Research Square) (2020)
Open Access
Page 1

Scroll to top